BriaCell Therapeutics Corp. - BCTX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$65K
QoQ value delta ($000)
-$66K
(-50.38%)
Implied price effect (QoQ)
-36.56%
Shares
Total shares
9,696
QoQ shares delta
-2,700
(-21.78%)
Total shares held by funds (by quarter)
Market chart (BCTX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 16 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| FLAGSHIP HARBOR ADVISORS, LLC | 28 | 4,000 | 0.0% |
| MORGAN STANLEY | 24 | 3,501 | 0.0% |
| Federation des caisses Desjardins du Quebec | 8 | 1,205 | 0.0% |
| UBS Group AG | 4 | 638 | 0.0% |
| ROYAL BANK OF CANADA | 1 | 100 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 1 | 0.0% |
| GROUP ONE TRADING LLC | 0 | 70 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 9 | 0.0% |
| Allworth Financial LP | 0 | 100 | 0.0% |
| FNY Investment Advisers, LLC | 0 | 10 | 0.0% |
| HHM Wealth Advisors, LLC | 0 | 6 | 0.0% |
| TD Waterhouse Canada Inc. | 0 | 19 | 0.0% |
| SSA SWISS ADVISORS AG | 0 | 37 | 0.0% |